HDAC3 functions as a positive regulator in Notch signal transduction
Francesca Ferrante, Benedetto Daniele Giaimo, Marek Bartkuhn, Tobias Zimmermann, Viola Close, Daniel Mertens, Andrea Nist, Thorsten Stiewe, Johanna Meier-Soelch, Michael Kracht, Steffen Just, Patricia Klöble, Franz Oswald, Tilman Borggrefe, Francesca Ferrante, Benedetto Daniele Giaimo, Marek Bartkuhn, Tobias Zimmermann, Viola Close, Daniel Mertens, Andrea Nist, Thorsten Stiewe, Johanna Meier-Soelch, Michael Kracht, Steffen Just, Patricia Klöble, Franz Oswald, Tilman Borggrefe
Abstract
Aberrant Notch signaling plays a pivotal role in T-cell acute lymphoblastic leukemia (T-ALL) and chronic lymphocytic leukemia (CLL). Amplitude and duration of the Notch response is controlled by ubiquitin-dependent proteasomal degradation of the Notch1 intracellular domain (NICD1), a hallmark of the leukemogenic process. Here, we show that HDAC3 controls NICD1 acetylation levels directly affecting NICD1 protein stability. Either genetic loss-of-function of HDAC3 or nanomolar concentrations of HDAC inhibitor apicidin lead to downregulation of Notch target genes accompanied by a local reduction of histone acetylation. Importantly, an HDAC3-insensitive NICD1 mutant is more stable but biologically less active. Collectively, these data show a new HDAC3- and acetylation-dependent mechanism that may be exploited to treat Notch1-dependent leukemias.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.
Figures
References
- Radtke F., MacDonald H.R., Tacchini-Cottier F.. Regulation of innate and adaptive immunity by Notch. Nat. Rev. Immunol. 2013; 13:427–437.
- Rothenberg E.V. Transcriptional control of early T and B cell developmental choices. Annu. Rev. Immunol. 2014; 32:283–321.
- Koch U., Radtke F.. Notch and cancer: a double-edged sword. Cell Mol. Life Sci. 2007; 64:2746–2762.
- Aster J.C., Pear W.S., Blacklow S.C.. The varied roles of notch in cancer. Annu. Rev. Pathol. 2017; 12:245–275.
- Roy M., Pear W.S., Aster J.C.. The multifaceted role of Notch in cancer. Curr. Opin. Genet. Dev. 2007; 17:52–59.
- Giaimo B.D., Borggrefe T.. Introduction to molecular mechanisms in notch signal transduction and disease pathogenesis. Adv. Exp. Med. Biol. 2018; 1066:3–30.
- Weng A.P., Ferrando A.A., Lee W., Morris J.P.t., Silverman L.B., Sanchez-Irizarry C., Blacklow S.C., Look A.T., Aster J.C.. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004; 306:269–271.
- Puente X.S., Pinyol M., Quesada V., Conde L., Ordonez G.R., Villamor N., Escaramis G., Jares P., Bea S., Gonzalez-Diaz M. et al. .. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 2011; 475:101–105.
- Thompson B.J., Buonamici S., Sulis M.L., Palomero T., Vilimas T., Basso G., Ferrando A., Aifantis I.. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J. Exp. Med. 2007; 204:1825–1835.
- O’Neil J., Grim J., Strack P., Rao S., Tibbitts D., Winter C., Hardwick J., Welcker M., Meijerink J.P., Pieters R. et al. .. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J. Exp. Med. 2007; 204:1813–1824.
- Borggrefe T., Oswald F.. The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol. Life Sci. 2009; 66:1631–1646.
- Giaimo B.D., Oswald F., Borggrefe T.. Dynamic chromatin regulation at Notch target genes. Transcription. 2017; 8:61–66.
- Bray S.J. Notch signalling in context. Nat. Rev. Mol. Cell Biol. 2016; 17:722–735.
- Kovall R.A., Gebelein B., Sprinzak D., Kopan R.. The canonical notch signaling pathway: structural and biochemical insights into shape, Sugar, and Force. Dev. Cell. 2017; 41:228–241.
- Yuan Z., VanderWielen B.D., Giaimo B.D., Pan L., Collins C.E., Turkiewicz A., Hein K., Oswald F., Borggrefe T., Kovall R.A.. Structural and functional studies of the RBPJ-SHARP Complex reveal a conserved corepressor binding site. Cell Rep. 2019; 26:845–854.
- Liefke R., Oswald F., Alvarado C., Ferres-Marco D., Mittler G., Rodriguez P., Dominguez M., Borggrefe T.. Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex. Genes Dev. 2010; 24:590–601.
- Jung C., Mittler G., Oswald F., Borggrefe T.. RNA helicase Ddx5 and the noncoding RNA SRA act as coactivators in the Notch signaling pathway. Biochim. Biophys. Acta. 2013; 1833:1180–1189.
- Oswald F., Rodriguez P., Giaimo B.D., Antonello Z.A., Mira L., Mittler G., Thiel V.N., Collins K.J., Tabaja N., Cizelsky W. et al. .. A phospho-dependent mechanism involving NCoR and KMT2D controls a permissive chromatin state at Notch target genes. Nucleic Acids Res. 2016; 44:4703–4720.
- Xu T., Park S.S., Giaimo B.D., Hall D., Ferrante F., Ho D.M., Hori K., Anhezini L., Ertl I., Bartkuhn M. et al. .. RBPJ/CBF1 interacts with L3MBTL3/MBT1 to promote repression of Notch signaling via histone demethylase KDM1A/LSD1. EMBO J. 2017; 36:3232–3249.
- Giaimo B.D., Ferrante F., Vallejo D.M., Hein K., Gutierrez-Perez I., Nist A., Stiewe T., Mittler G., Herold S., Zimmermann T. et al. .. Histone variant H2A.Z deposition and acetylation directs the canonical Notch signaling response. Nucleic Acids Res. 2018; 46:8197–8215.
- Fryer C.J., White J.B., Jones K.A.. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol. Cell. 2004; 16:509–520.
- Hein K., Mittler G., Cizelsky W., Kuhl M., Ferrante F., Liefke R., Berger I.M., Just S., Strang J.E., Kestler H.A. et al. .. Site-specific methylation of Notch1 controls the amplitude and duration of the Notch1 response. Sci Signal. 2015; 8:ra30.
- Popko-Scibor A.E., Lindberg M.J., Hansson M.L., Holmlund T., Wallberg A.E.. Ubiquitination of Notch1 is regulated by MAML1-mediated p300 acetylation of Notch1. Biochem. Biophys. Res. Commun. 2011; 416:300–306.
- Guarani V., Deflorian G., Franco C.A., Kruger M., Phng L.K., Bentley K., Toussaint L., Dequiedt F., Mostoslavsky R., Schmidt M.H. et al. .. Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature. 2011; 473:234–238.
- Palermo R., Checquolo S., Giovenco A., Grazioli P., Kumar V., Campese A.F., Giorgi A., Napolitano M., Canettieri G., Ferrara G. et al. .. Acetylation controls Notch3 stability and function in T-cell leukemia. Oncogene. 2012; 31:3807–3817.
- Borggrefe T., Lauth M., Zwijsen A., Huylebroeck D., Oswald F., Giaimo B.D.. The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFbeta/BMP and hypoxia pathways. Biochim. Biophys. Acta. 2016; 1863:303–313.
- Li Y., Seto E.. HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb. Perspect. Med. 2016; 6:a026831.
- Haberland M., Montgomery R.L., Olson E.N.. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 2009; 10:32–42.
- Zhang Y., Iratni R., Erdjument-Bromage H., Tempst P., Reinberg D.. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell. 1997; 89:357–364.
- Zhang Y., Ng H.H., Erdjument-Bromage H., Tempst P., Bird A., Reinberg D.. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 1999; 13:1924–1935.
- Humphrey G.W., Wang Y., Russanova V.R., Hirai T., Qin J., Nakatani Y., Howard B.H.. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J. Biol. Chem. 2001; 276:6817–6824.
- Wen Y.D., Perissi V., Staszewski L.M., Yang W.M., Krones A., Glass C.K., Rosenfeld M.G., Seto E.. The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc. Natl. Acad. Sci. U.S.A. 2000; 97:7202–7207.
- Li J., Wang J., Wang J., Nawaz Z., Liu J.M., Qin J., Wong J.. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 2000; 19:4342–4350.
- Yoon H.G., Chan D.W., Huang Z.Q., Li J., Fondell J.D., Qin J., Wong J.. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 2003; 22:1336–1346.
- Yoon H.G., Chan D.W., Reynolds A.B., Qin J., Wong J.. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol. Cell. 2003; 12:723–734.
- Guenther M.G., Lane W.S., Fischle W., Verdin E., Lazar M.A., Shiekhattar R.. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev. 2000; 14:1048–1057.
- Zhang J., Kalkum M., Chait B.T., Roeder R.G.. The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell. 2002; 9:611–623.
- Kao H.Y., Ordentlich P., Koyano-Nakagawa N., Tang Z., Downes M., Kintner C.R., Evans R.M., Kadesch T.. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev. 1998; 12:2269–2277.
- Oswald F., Kostezka U., Astrahantseff K., Bourteele S., Dillinger K., Zechner U., Ludwig L., Wilda M., Hameister H., Knochel W. et al. .. SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway. EMBO J. 2002; 21:5417–5426.
- Mikami S., Kanaba T., Ito Y., Mishima M.. NMR assignments of SPOC domain of the human transcriptional corepressor SHARP in complex with a C-terminal SMRT peptide. Biomol. NMR Assign. 2013; 7:267–270.
- Mikami S., Kanaba T., Takizawa N., Kobayashi A., Maesaki R., Fujiwara T., Ito Y., Mishima M.. Structural insights into the recruitment of SMRT by the corepressor SHARP under phosphorylative regulation. Structure. 2014; 22:35–46.
- Chen X., Barozzi I., Termanini A., Prosperini E., Recchiuti A., Dalli J., Mietton F., Matteoli G., Hiebert S., Natoli G.. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc. Natl. Acad. Sci. U.S.A. 2012; 109:E2865–E2874.
- Ziesche E., Kettner-Buhrow D., Weber A., Wittwer T., Jurida L., Soelch J., Muller H., Newel D., Kronich P., Schneider H. et al. .. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-kappaB. Nucleic Acids Res. 2013; 41:90–109.
- Zhang L., He X., Liu L., Jiang M., Zhao C., Wang H., He D., Zheng T., Zhou X., Hassan A. et al. .. Hdac3 interaction with p300 histone acetyltransferase regulates the oligodendrocyte and astrocyte lineage fate switch. Dev. Cell. 2016; 36:316–330.
- Palomero T., Barnes K.C., Real P.J., Glade Bender J.L., Sulis M.L., Murty V.V., Colovai A.I., Balbin M., Ferrando A.A.. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors. Leukemia. 2006; 20:1279–1287.
- Oswald F., Tauber B., Dobner T., Bourteele S., Kostezka U., Adler G., Liptay S., Schmid R.M.. p300 acts as a transcriptional coactivator for mammalian Notch-1. Mol. Cell Biol. 2001; 21:7761–7774.
- Yang W.M., Tsai S.C., Wen Y.D., Fejer G., Seto E.. Functional domains of histone deacetylase-3. J. Biol. Chem. 2002; 277:9447–9454.
- de la Vega L., Grishina I., Moreno R., Kruger M., Braun T., Schmitz M.L.. A redox-regulated SUMO/acetylation switch of HIPK2 controls the survival threshold to oxidative stress. Mol. Cell. 2012; 46:472–483.
- Giaimo B.D., Ferrante F., Borggrefe T.. Chromatin immunoprecipitation (ChIP) in mouse T-cell lines. J. Vis. Exp. 2017; doi:10.3791/55907.
- Dieguez-Hurtado R., Kato K., Giaimo B.D., Nieminen-Kelha M., Arf H., Ferrante F., Bartkuhn M., Zimmermann T., Bixel M.G., Eilken H.M. et al. .. Loss of the transcription factor RBPJ induces disease-promoting properties in brain pericytes. Nat. Commun. 2019; 10:2817.
- Trapnell C., Pachter L., Salzberg S.L.. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009; 25:1105–1111.
- Langmead B. Aligning short sequencing reads with Bowtie. Curr. Protoc. Bioinformatics. 2010; doi:10.1002/0471250953.bi1107s32.
- Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J. et al. .. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004; 5:R80.
- Lawrence M., Huber W., Pages H., Aboyoun P., Carlson M., Gentleman R., Morgan M.T., Carey V.J.. Software for computing and annotating genomic ranges. PLoS Comput. Biol. 2013; 9:e1003118.
- Love M.I., Huber W., Anders S.. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15:550.
- Bengtsson H., Simpson K., Bullard J., Hansen K.. aroma.affymetrix: A generic framework in R for analyzingsmall to very large Affymetrix data sets in bounded memory. 2008; .
- Feng J., Liu T., Qin B., Zhang Y., Liu X.S.. Identifying ChIP-seq enrichment using MACS. Nat. Protoc. 2012; 7:1728–1740.
- Feng X., Grossman R., Stein L.. PeakRanger: a cloud-enabled peak caller for ChIP-seq data. BMC Bioinformatics. 2011; 12:139.
- Machanick P., Bailey T.L.. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics. 2011; 27:1696–1697.
- Homminga I., Pieters R., Langerak A.W., de Rooi J.J., Stubbs A., Verstegen M., Vuerhard M., Buijs-Gladdines J., Kooi C., Klous P. et al. .. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell. 2011; 19:484–497.
- Wang L., Shalek A.K., Lawrence M., Ding R., Gaublomme J.T., Pochet N., Stojanov P., Sougnez C., Shukla S.A., Stevenson K.E. et al. .. Somatic mutation as a mechanism of Wnt/beta-catenin pathway activation in CLL. Blood. 2014; 124:1089–1098.
- Gomez-Abad C., Pisonero H., Blanco-Aparicio C., Roncador G., Gonzalez-Menchen A., Martinez-Climent J.A., Mata E., Rodriguez M.E., Munoz-Gonzalez G., Sanchez-Beato M. et al. .. PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma. Blood. 2011; 118:5517–5527.
- Seifert M., Sellmann L., Bloehdorn J., Wein F., Stilgenbauer S., Durig J., Kuppers R.. Cellular origin and pathophysiology of chronic lymphocytic leukemia. J. Exp. Med. 2012; 209:2183–2198.
- Van Vlierberghe P., Ambesi-Impiombato A., Perez-Garcia A., Haydu J.E., Rigo I., Hadler M., Tosello V., Della Gatta G., Paietta E., Racevskis J. et al. .. ETV6 mutations in early immature human T cell leukemias. J. Exp. Med. 2011; 208:2571–2579.
- Davis S., Meltzer P.S.. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007; 23:1846–1847.
- Just S., Berger I.M., Meder B., Backs J., Keller A., Marquart S., Frese K., Patzel E., Rauch G.J., Katus H.A. et al. .. Protein kinase D2 controls cardiac valve formation in zebrafish by regulating histone deacetylase 5 activity. Circulation. 2011; 124:324–334.
- Chan S.K.K., Cerda-Moya G., Stojnic R., Millen K., Fischer B., Fexova S., Skalska L., Gomez-Lamarca M., Pillidge Z., Russell S. et al. .. Role of co-repressor genomic landscapes in shaping the Notch response. PLos Genet. 2017; 13:e1007096.
- Weng A.P., Nam Y., Wolfe M.S., Pear W.S., Griffin J.D., Blacklow S.C., Aster J.C.. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol. Cell Biol. 2003; 23:655–664.
- Fang T.C., Yashiro-Ohtani Y., Del Bianco C., Knoblock D.M., Blacklow S.C., Pear W.S.. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity. 2007; 27:100–110.
- Lin S., Tian L., Shen H., Gu Y., Li J.L., Chen Z., Sun X., You M.J., Wu L.. DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia. Oncogene. 2013; 32:4845–4853.
- Ryan R.J.H., Petrovic J., Rausch D.M., Zhou Y., Lareau C.A., Kluk M.J., Christie A.L., Lee W.Y., Tarjan D.R., Guo B. et al. .. A B cell regulome links notch to downstream oncogenic pathways in small B cell lymphomas. Cell Rep. 2017; 21:784–797.
- Marcel N., Perumalsamy L.R., Shukla S.K., Sarin A.. The lysine deacetylase Sirtuin 1 modulates the localization and function of the Notch1 receptor in regulatory T cells. Sci Signal. 2017; 10:eaah4679.
- Horvath M., Mihajlovic Z., Slaninova V., Perez-Gomez R., Moshkin Y., Krejci A.. The silent information regulator 1 (Sirt1) is a positive regulator of the Notch pathway in Drosophila. Biochem. J. 2016; 473:4129–4143.
- Antila C.J.M., Rraklli V., Blomster H.A., Dahlstrom K.M., Salminen T.A., Holmberg J., Sistonen L., Sahlgren C.. Sumoylation of Notch1 represses its target gene expression during cell stress. Cell Death Differ. 2018; 25:600–615.
- Murtomaki A., Uh M.K., Kitajewski C., Zhao J., Nagasaki T., Shawber C.J., Kitajewski J.. Notch signaling functions in lymphatic valve formation. Development. 2014; 141:2446–2451.
- Janardhan H.P., Milstone Z.J., Shin M., Lawson N.D., Keaney J.F. Jr, Trivedi C.M.. Hdac3 regulates lymphovenous and lymphatic valve formation. J. Clin. Invest. 2017; 127:4193–4206.
- Jiao F., Hu H., Yuan C., Jin Z., Guo Z., Wang L., Wang L.. Histone deacetylase 3 promotes pancreatic cancer cell proliferation, invasion and increases drug-resistance through histone modification of P27, P53 and Bax. Int. J. Oncol. 2014; 45:1523–1530.
- Knutson S.K., Chyla B.J., Amann J.M., Bhaskara S., Huppert S.S., Hiebert S.W.. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. 2008; 27:1017–1028.
- Schmitz M.L., de la Vega L.. New insights into the role of histone deacetylases as coactivators of inflammatory gene expression. Antioxid. Redox. Signal. 2015; 23:85–98.
- Oberg C., Li J., Pauley A., Wolf E., Gurney M., Lendahl U.. The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J. Biol. Chem. 2001; 276:35847–35853.
Source: PubMed